Continuous administration of natural GLP-1 increases insulin levels and results in lower blood glucose and hemoglobin A1C (HbA1c) levels in patients with type 2 diabetes mellitus (T2DM) (20)
What Consumers Should Know About GLP-1 Evidence and FeelGood's Brand-Stated Outcome Claims There are two separate issues consumers should not confuse: the clinical evidence for FDA-approved GLP-1 medications in appropriate patients, and FeelGood's brand-stated outcome claims for its own telehealth program
Green JB, Mottl AK, Bakris G, Heerspink HJL, Mann JFE, McGill JB, Nangaku M, Rossing P, Scott C, Gay A, et al
How should BAC Water 30Ml be stored
Some pharmacies may still have temporary local supply gaps